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Transthoracic needle biopsy (TTNB) of the lung is a well-established technique for diagnosing many
thoracic lesions, and is an important alternative to more invasive surgical procedures. Complications of
TTNB include pneumothorax, hemoptysis, hemothorax, infection, and air embolism, with the most
common complication as pneumothorax. From June 2011 to June 2014 we performed a prospective study
of 188 patients who underwent TTNB with CT guidance at University Hospital of Salerno, Italy. Pneu-
mothorax occurred in 14 of 188 biopsies (7.45%). With the respect of age of patients pneumothorax
occurred more frequently in patients aged 60e70 years, while it was less frequent in younger (<60 years)
and older patients (>70 years). In conclusion, data of our prospective study documented that CT-guided
TTNB is a safe and reliable procedure in elderly patients with suspected chest malignancy and is well
tolerated.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Transthoracic needle biopsy (TTNB) of the lung is a well-
established technique for diagnosing many thoracic lesions, and
is an important alternative to more invasive surgical procedures.
Commonly employed modalities for imaging-guided percutaneous
needle biopsy include ultrasound and conventional computed to-
mography (CT), which has become more widely used [1]. In-
dications for TTNB are pulmonary lesions inaccessible to
bronchoscopy, or in which prior bronchoscopic biopsy was non-
diagnostic and mediastinal or pleural mass [2,3]. The most impor-
tant contraindications for TTNB are: poor respiratory function or
reserve, abnormal coagulation indices, bleeding diatheses, severe
bullous emphysema, contralateral pneumonectomy, hydatid cyst,and Surgery, University of
nissi, Salerno, Italy.
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tolerate a pneumothorax [4e7].
Complications of TTNB include pneumothorax, hemoptysis,
hemothorax, infection, and air embolism, with the most common
complication as pneumothorax [8,9]. Pneumothoraces can occur
during or immediately after the procedure, which is why it is
important to perform a CT scan of the region following removal of
the needle [8]. The incidence of pneumothorax in patients under-
going TTNB has been reported to be from 9% to 54%, according to
reports published in the past ten years [10e15], with an average of
around 20% [16]. Risk factors for the development of pneumothorax
after TTNB include the presence of chronic obstructive pulmonary
disease (COPD), small lesion size, lesion depth, and repeated pleural
puncture [6]. Increased patient age has been reported to represent a
possible risk factor [17], however the occurrence of pneumothorax
after TTNB in older patients has been scarcely evaluated. Therefore
we performed a prospective study to evaluate the signiﬁcance of
age as a risk factor in the occurrence of pneumothorax after TTNB.2. Materials and methods
From June 2011 to June 2014 we performed a prospective study
of 188 patients who underwent TTNB with CT guidance at.
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performing CT-TTNB for inpatients only and of taking immediate CT
after CT-TTNB and chest PA. Before the beginning of each proce-
dure, the risks and beneﬁts of TTNB were discussed, and informed
consent was obtained from each patient. The biopsy of peripheral
lesions was often performed directly using a 20 or 22-gauge needle
(Chibell, Biopsybell, Modena, Italy) (See Fig. 1). The procedure was
performed with the patient in a prone, supine, or lateral decubitus
position, depending on the location of the lesion. A cytotechnolo-
gist was present during all procedures, and specimens were
immediately processed and stained to determine if there was suf-
ﬁcient cellularity to make a diagnosis. The ﬁne needle cytology
procedures and the ancillary techniques have been extensively
described elsewhere [18e27].
After biopsy, all patients were placed in the decubitus position
to compress the biopsy site. To conﬁrm the occurrence of pneu-
mothorax (PNX), chest posteroanterior radiographs (PAs) using a
digital imaging system and displayed by a picture archiving and
communication system (PACS) were performed when simulta-
neously done CT showed a PNX or patient's condition was sug-
gestive for PNX. If PAs showed a PNX <3 cm the patient was treated
conservatively with monitoring of vital signs, administration of
supplemental oxygen, and follow-up chest radiography at 6 and
24 h to value the stability of the pneumothorax. If the patient
presented symptoms such as dyspnea or respiratory distress,
aspiration of the pneumothorax was attempted. If aspiration was
inadequate or if a large or rapidly enlarging pneumothorax was
found, a tube was placed in the patient's chest. All patients who
underwent chest tube placement were admitted to a surveillance
unit where the tube was connected for at least 24 h to a closed
pleural drainage and collection system set to deliver 20 cm of water
pressure with moderate continuous wall suction. The next morn-
ing, suction was discontinued, the tube was placed to the water
seal, and chest radiography was repeated. If the pneumothorax
resolved, the chest tube was removed and the patient was dis-
charged. If the pneumothorax persisted, the chest tube was kept in
place for another day and the process was repeated.
Statistical analysis was performed using commercially available
software (SPSS 10.0 for Windows; SPSS; Chicago, IL). QuantitativeFig. 1. A CT scan of a needle inserted into the lung to obtain a sample for biopsy.variables were compared using the unpaired t test, and qualitative
variables were compared using the c2 test.
3. Results
One hundred eighty-eight patients (142 males and 46 females,
with age from 29 to 94 years (average 69.7) were included in the
study. Pneumothorax occurred in 14 of 188 biopsies (7.45%). Four
patients with pneumothorax required pleural drains; one was
discharged the following day and three other required drainage for
3 days. Hemoptysis was not a problem but occurred as a transient
after biopsy event in ﬁve patients. With the respect of age no sta-
tistical difference was detected in the occurrence of pneumothorax,
however it developed more frequently in patients aged 60e70
years, while it was less frequent in younger (<60 years) and older
patients (>70 years) (See Fig. 2).
4. Discussion
CT-guided TNNB is one of the most used procedure in the
diagnosis of tumoral and non tumoral lung pathologies [28e34]. It
is regarded as a safe procedure with limited morbidity and
extremely rare mortality. In deciding whether to pursue TTNB of a
lung lesion, it should be considered the risk factors that may in-
crease the individual patient's risk of complications. Important
considerations include the presence of comorbidities such as COPD
and the size and location of the lesion. The incidence of pneumo-
thorax in patients undergoing TTNB has been reported to vary from
9 to 54%, according to reports published in the past ten years, with
an average of around 20%. In our study we detected a very low
incidence of pneumothorax. In fact, only fourteen on one hundred
eighty-eight (7.45%) patients experienced pneumothorax after
TTNB. Increased patient age has been reported to represent a
possible risk factor. There are few reports of transthoracic needle
biopsy in elderly (>70 years) patients although there is some evi-
dence that age may be a risk factor in developing pneumothorax.
The weakening of elastic recoil in aged lung parenchyma may
facilitate the occurrence of pneumothorax after TTNB. In our study
the highest percentage of pneumothorax was detected in patients
aged 60e70 years while a lower risk was found in younger (<60
years) and in older (>70 years) patients. Our data are similar to that
of Wiener [35] et al. who in a multi-center study found risk of
pneumothorax to be highest in patients aged 60e69 years, with a
lower risk in young patients (likely reﬂecting a healthier, more
robust population) and in elderly patients (likely reﬂecting a se-
lection bias through which frail patients at high risk ofFig. 2. PNX after TTNB percentage grouped by age.
A. Vatrella et al. / International Journal of Surgery 12 (2014) S29eS32 S31complications were not referred to biopsy). In conclusion, pneu-
mothorax after TTNB is a widely reported complication. Its occur-
rence is not easy to predict. Many reports have suggested that age
may represent a possible risk factor but data of our prospective
study documented that CT-guided TTNB is a safe and reliable pro-
cedure in elderly patients with suspected chest malignancy and is
well tolerated.
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